PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 161 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $20,823,000 | -39.8% | 916,927 | -37.5% | 1.66% | -49.9% |
| Q2 2016 | $34,610,000 | +90.7% | 1,466,537 | +64.9% | 3.31% | +78.0% |
| Q1 2016 | $18,148,000 | -63.2% | 889,607 | -7.2% | 1.86% | -49.7% |
| Q4 2015 | $49,297,000 | +50.3% | 958,155 | +24.5% | 3.69% | +48.5% |
| Q3 2015 | $32,802,000 | +371.6% | 769,641 | +404.0% | 2.48% | +336.0% |
| Q2 2015 | $6,955,000 | -40.6% | 152,700 | -66.2% | 0.57% | -59.2% |
| Q1 2014 | $11,712,000 | – | 452,194 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |